Trials / Terminated
TerminatedNCT04827732
Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in Recurrent Rectal Cancer
Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in the Reirradiation of Locoregionally Recurrent Rectal Cancer - IMPARC
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine the maximum tolerated dose (MTD) of hypofractionated IMPT for the reirradiation of locoregionally recurrent rectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy | When feasible it is strongly recommended that radiotherapy begin on a Monday |
| DEVICE | MEVION S250i Hyperscan and Adaptive Aperture Proton Therapy Machine | -The device that will administer the IMPT |
Timeline
- Start date
- 2021-05-04
- Primary completion
- 2024-07-29
- Completion
- 2024-11-18
- First posted
- 2021-04-01
- Last updated
- 2025-09-29
- Results posted
- 2025-09-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04827732. Inclusion in this directory is not an endorsement.